The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy
Open accessAbstract
OBJECTIVE AND METHODS: Idiopathic interstitial pneumonias (IIPs) frequently occur in association with lung cancer. However, there is no consensus on the best treatment of acute exacerbation of IIP in lung cancer patients (LC with IIP), including those with iatrogenic acute lung injury resulting from cancer treatments. We aimed to identify an appropriate strategy for treatment of this condition. We analyzed clinical features of 120 LC with IIP, retrospectively. RESULTS: The incidence of acute exacerbation related to anticancer treatment was 22.7%; when the incidence was examined separately for patients receiving chemotherapy or the best supportive care, the incidence was 20.0% and 31.3%, respectively. Additional investigations should be directed to finding suitable regimens for treatment of LC with IIP and the selection of appropriate patients with LC with IIP for chemotherapy. The incidence of acute exacerbation caused by combination regimens of carboplatin + paclitaxel or a platinum agent + etoposide was significantly lower than that of other regimens (0% vs. 18%, respectively; p=0.025, Fisher's Exact Test). Patients with high levels of C-reactive protein before chemotherapy had a significantly higher risk of developing acute exacerbation (odds ratio 5.60, p=0.028). CONCLUSION: There was no evidence that anticancer treatment, including chemotherapy, should be avoided in LC with IIP. To establish an appropriate cancer treatment for LC with IIP, a prospective clinical study should be performed to evaluate various treatment modalities in a larger patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, drug‑induced lung injury occurs more frequently in groups with high CRP, SUVmax, or GPS(32‑34).”
From Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy. (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 955
Self-citationLung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study
Hubbard, R., Venn, A. J., Lewis, S., & Britton, J. R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9906062 · Cited by 637
Interstitial Lung Disease in Japanese Patients with Lung Cancer
Kudoh, S., Kato, H., Nishiwaki, Y., Fukuoka, M., Nakata, K., Ichinose, Y., Tsuboi, M., Yokota, S., Nakagawa, K., Suga, M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1501oc · Cited by 477
Self-citationAcute Exacerbation in Idiopathic Pulmonary Fibrosis
Kondoh, Y., Taniguchi, H., Kawabata, Y., Yokoi, T., Suzuki, K., & Takagi, K. (1993) · CHEST Journal · doi:10.1378/chest.103.6.1808 · Cited by 457
Raghu, G., Mageto, Y. N., Lockhart, D., Schmidt, R. A., Wood, D. E., & Godwin, J. D. (1999) · CHEST Journal · doi:10.1378/chest.116.5.1168 · Cited by 401
Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment
Panos, R. J., Mortenson, R. L., Niccoli, S. A., & King, T. E. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90495-y · Cited by 367
Cryptogenic fibrosing alveolitis and lung cancer.
Turner-Warwick, M. E. H., Lebowitz, M. D., Burrows, B. A., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.7.496 · Cited by 348
Anscher, M. S., Peters, W. P., Reisenbichler, H., Petros, W. P., & Jirtle, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282203 · Cited by 316
Akira, M., Hamada, H., Sakatani, M., Kobayashi, C., Nishioka, M., & Yamamoto, S. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.1.8976924 · Cited by 298
Research works printed but not linked: 6
- UEMATSU K, 2001, Cancer Res, 61, 8527
- KOIZUMI K, 2004, Ann Thorac Cardiovasc Surg, 10, 340
- American Thoracic Society, 2002, Am J Respir Crit Care Med, 165, 277, 10.1164/ajrccm.165.2.ats01 · DOI · Paper page
- Takeuchi E, Yamaguchi T, Mori M, et, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, 34, 653
- Gemma A, Seike M, Kosaihira S, et a, 2006, Anticancer Res, 26, 3083
- Fukushima K, Kawabata Y, Uchiyama T, 1999, Nihon Kokyuuki Gakkai Zassi, 37, 177
Cited by
Sorted by citations
Items 101–128 of 128
Cordeiro, C. R., Alfaro, T. M., Freitas, S., & Cemlyn-Jones, J. M. (2015) · European Respiratory Society eBooks · doi:10.1183/2312508x.10009414 · Cited by 3
Karapınar, K., Yurt, S., Toptaş, M., Bahadır, A., Erdoğu, V., Akçıl, A. M., & Önür, S. T. (2024) · Medicine · doi:10.1097/md.0000000000037186 · Cited by 3
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
Cottin, V., & Cordier, J.-F. (2014) · Springer eBooks · doi:10.1007/978-1-4471-2401-6_22 · Cited by 3
Kashiwabara, K., Semba, H., Fujii, S., Tsumura, S., & Aoki, R. (2015) · Cancer Investigation · doi:10.3109/07357907.2015.1069832 · Cited by 3
Akaike, K., Saruwatari, K., Okabayashi, H., Hamada, S., Jodai, Y., Jodai, T., Sakata, S., Iyama, S., Sato, R., Iriki, T., et al. (2018) · Anticancer Research · doi:10.21873/anticanres.13020 · Cited by 3
Ogawa, K., Takahashi, Y., Murase, K., Hanada, S., Uruga, H., Takaya, H., Miyamoto, A., Morokawa, N., Kurosaki, A., & Kishi, K. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.02.004 · Cited by 3
Yamaguchi, M., Seto, T., Furuya, A., Edagawa, M., Shimamatsu, S., Toyozawa, R., Toyokawa, G., Nosaki, K., Hirai, F., Takenoyama, M., et al. (2016) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2016.08.011 · Cited by 2
Matsubara, T., Shimokawa, M., Wakasu, S., Haro, A., Yamaguchi, M., & Hamatake, M. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108591 · Cited by 2
Pneumomediastinum as a complication of SABR for lung metastases
Rodriguez-Ruiz, M. E., Arevalo, E., Bazo, I. G., Garcia, A. O., Valtueña, G., Moreno, M., Arbea, L., & Aristu, J. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0330-y · Cited by 2
Nakajima, Y., Akiyama, H., Kinoshita, H., Atari, M., Fukuhara, M., Sakai, H., & Uramoto, H. (2015) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2015.11.027 · Cited by 2
Isobe, K., Hata, Y., Kaburaki, K., Sakamoto, S., Takai, Y., Tochigi, N., Iyoda, A., & Homma, S. A. (2014) · Haigan · doi:10.2482/haigan.54.761 · Cited by 2
Niwa, H., Otani, S., Nakada, N., Sasaki, J., Saka, H., & Masuda, N. (2018) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2018.01.006 · Cited by 2
Idiopathic pulmonary fibrosis: What has changed in the diagnosis and treatment from past to present?
Anar, C. M., Okutan, O., Şengül, A., Yazıcı, O., & Altınsoy, B. (2020) · Eurasian Journal of Pulmonology · doi:10.4103/ejop.ejop_45_19 · Cited by 1
Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer
Sakamoto, S., Kawakita, N., Takeuchi, T., Sumitomo, H., Miyamoto, N., Toba, H., Kondo, K., & Takizawa, H. (2024) · International Journal of Clinical Oncology · doi:10.1007/s10147-024-02600-5 · Cited by 1
Azumi, R., Soyama, M., & Saito, M. K. (2023) · Cureus · doi:10.7759/cureus.38275 · Cited by 1
Matsumoto, M., Minegishi, Y., Higa, K., Fukuizumi, A., Onda, N., Takeuchi, S., Miyanaga, A., Gemma, A., & Seike, M. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03459-y · Cited by 1
Self-citationCurrent Treatment Strategies for Lung Cancer Combined with Interstitial Lung Diseases
Satō, T. (2017) · Haigan · doi:10.2482/haigan.57.819 · Cited by 1
Acute Exacerbations in Patients With Idiopathic Pulmonary Fibrosis
Kim, D. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48024-6.00011-2 · Cited by 1
Kawamura, S., Kubo, T., Takada, K., Sunami, R., Okawa, S., Iwamoto, Y., Hirabae, A., Taniguchi, A., Maeda, Y., Kiura, K., et al. (2021) · International Cancer Conference Journal · doi:10.1007/s13691-021-00475-1 · Cited by 1
Idiopathic Interstitial Pneumonias Associated with Lung Cancer
Kagohashi, K., Miyazaki, K., & Satoh, H. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.2479
Minegishi, Y. (2011) · Journal of Nippon Medical School · doi:10.1272/jnms.78.50
Self-citationAcute Exacerbation of Interstitial Pneumonia After Pulmonary Resection for Lung Cancer
Date, H. (2015) · Springer eBooks · doi:10.1007/978-4-431-55582-7_15
Lung Cancer Complicated with Interstitial Lung Diseases
Minegishi, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-2002-5_15
Self-citationTobacco Smoking and Lung Cancer
Sakaguchi, H. (2017) · Nihon Kikan Shokudoka Gakkai Kaiho · doi:10.2468/jbes.68.339
Fukunaga, K., Nagatani, Y., Nakagawa, H., Nitta‐Seko, A., Nagata, T., Nishizono, M., Kobashi, K., Iguchi, H., Nitta, N., Hanaoka, J., et al. (2020) · doi:10.21203/rs.3.rs-19006/v1
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Jain, N. K., Jain, S., Mushtaq, H. A., Khedr, A., Koritala, T., Tekin, A., Adhikari, R., Sule, A. A., Gautam, S. C., Pattan, V., et al. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104610
Yamaguchi, T., Shimizu, J., Hasegawa, T., Horio, Y., Inaba, Y., Hanai, N., Muro, K., & Hida, T. (2021) · Figshare · doi:10.6084/m9.figshare.15179614
Yoon, H.-Y., Lee, S. H., Ha, S., Ryu, J.-S., & Song, J. W. (2021) · Figshare · doi:10.6084/m9.figshare.16632863
Metadata
- Authors
- Minegishi, Y., Takenaka, K., Mizutani, H., Sudoh, J., Noro, R., Okano, T., Azuma, A., Yoshimura, A., Ando, M., Tsuboi, E., Kudoh, S., & Gemma, A.
- Affiliations
- Nippon Medical School (JP)
- Division of Internal Medicine, Tsuboi Cancer Center Hospital
- Venue
- Internal Medicine
- Published
- 2009
- Volume
- 48
- Issue
- 9
- Pages
- 665-672
- ISSN
- 0918-2918 (ISSN-L)
- 1349-7235
- OpenAlex
- W2094116236
- Cited by
- 128
- References
- 34
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 15 · 2018: 10 · 2017: 17 · 2016: 4 · 2015: 16 · 2014: 9 · 2013: 3 · 2012: 6
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (21591006)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic interstitial pneumonia, lung cancer, acute exacerbation, chemotherapy-induced lung injury, carboplatin, paclitaxel, etoposide, platinum agents, C-reactive protein, best supportive care, treatment selection
- MeSH terms
- Aged, Aged, 80 and over, Antineoplastic Agents, Female, Humans, Lung Neoplasms, Male, Middle Aged, Retrospective Studies, Survival Rate, Idiopathic Interstitial Pneumonias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
